Latest News

  • Mogrify closes $46m in Series A funding

    Funding will support the advancement of Mogrify’s pipeline of in vivo reprogramming therapies. The biopharmaceutical company Mogrify has closed an additional US$10 million in Series A financing, bringing the total raised to US$46 million. The funding will support further advancement of Mogrify’s pipeline of in vivo reprogramming therapies through pre-clinical translation, continued platform optimisation and [...]

  • Scientific leaders get behind new longevity declaration

    The “Dublin Longevity Declaration” calls on public institutions to immediately expand research on extending healthy human lifespans. The Longevity Escape Velocity Foundation (LEVF) has released a declaration that calls on governments, funding agencies and the public to accelerate their support of the promising interventional ideas that aim to fight age-related suffering and disease. The "Dublin [...]

  • Positive results for experimental sarcopenia treatment

    There are currently no approved drug treatments for sarcopenia despite it affecting up to half of people aged over 80 years. A 6-week clinical proof-of-mechanism study examining RJx-01, a novel combination drug comprising galantamine and metformin, has demonstrated positive results among 42 elderly subjects. The drug is developed by Beligium-based firm, Rejuvenate Biomed, a clinical-stage [...]

  • Osteoporosis screening tool secures FDA Breakthrough Designation

    A new technology for estimating bone mineral density (BMD) from routine X-rays has received Breakthrough Device Designation from the US Food and Drug Administration (FDA).  OsteoSight was developed to address the unmet need for earlier diagnosis of osteoporosis, a condition characterised by a progressive decrease in bone density. Osteoporosis frequently goes unnoticed until a patient [...]

  • Homecare Hub raises $2.5 million in drive to redefine senior care

    Homecare Hub, a Canadian provider creating innovative home care and housing solutions, has set its sights on expansion following the close of an oversubscribed $2.5m seed funding round. With the raise, Homecare Hub has taken another step towards its promise to redefine senior care by providing affordable, high-quality alternatives to large institutional nursing homes through [...]

  • Spencer Health Solutions raises $43M to accelerate growth

    Spencer Health Solutions has raised $43 million to accelerate the growth of its medication adherence platform in global markets. The health technology company is focused on improving patient engagement and medication adherence for clinical trials and commercial pharmaceutical programs, while also provider better support for patients at home. Its spencer® medication dispensing technology, a data-driven [...]

  • The online club helping inspire a more joyful retirement

    The founder of an online activity club providing inspiration for a happier and more fulfilling retirement has told Agetech World she believes a link-up with the NHS could have “huge benefits” for both older people and the UK’s publicly funded healthcare system. Hannah Thomson was inspired by her late grandmother to launch The Joy Club [...]

  • New technology enables selective removal of ageing cells

    A team of researchers in South Korea has achieved a "significant breakthrough" in the treatment of age-related diseases. Technology developed by scientists at the Department of Chemistry at UNIST and Konkuk University offers a promising new approach to treating age-related diseases. The technology works by selectively removing ageing cells without harming normal healthy cells. The [...]

  • Study uncovers how age of diabetes diagnosis impacts life expectancy

    Being diagnosed with type 2 diabetes by the age of 30 could see life expectancy fall by as much as 14 years, according to an international team of researchers. Published in The Lancet Diabetes & Endocrinology, the study emphasises a pressing need to develop and implement interventions that prevent or delay the onset of diabetes. [...]

  • “Anti-tangle” molecule could aid search for new dementia treatments

    UK researchers have identified a molecule that can prevent tangling of a brain protein that is linked to diseases such as Parkinson’s. The discovery may provide insights into new ways of treating or diagnosing the early stages of dementia. Alpha-synuclein, a protein found in brain cells, is commonly associated with neurodegenerative conditions such as Parkinson's. [...]